TY - JOUR T1 - Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases JF - medRxiv DO - 10.1101/2020.02.21.20021618 SP - 2020.02.21.20021618 AU - Guillermo Barturen AU - Sepideh Babaei AU - Francesc Català-Moll AU - Manuel Martínez-Bueno AU - Zuzanna Makowska AU - Jordi Martorell-Marugán AU - Pedro Carmona-Sáez AU - Daniel Toro-Domínguez AU - Elena Carnero-Montoro AU - María Teruel AU - Martin Kerick AU - Marialbert Acosta-Herrera AU - Lucas Le Lann AU - Christophe Jamin AU - Javier Rodríguez-Ubreva AU - Antonio García-Gómez AU - Jorge Kageyama AU - Anne Buttgereit AU - Sikander Hayat AU - Joerg Mueller AU - Ralf Lesche AU - Maria Hernandez-Fuentes AU - Maria Juarez AU - Tania Rowley AU - Ian White AU - Concepción Marañón AU - Tania Gomes Anjos AU - Nieves Varela AU - Rocío Aguilar-Quesada AU - Francisco Javier Garrancho AU - Antonio López-Berrio AU - Manuel Rodriguez Maresca AU - Héctor Navarro-Linares AU - Isabel Almeida AU - Nancy Azevedo AU - Mariana Brandão AU - Ana Campar AU - Raquel Faria AU - Fátima Farinha AU - António Marinho AU - Esmeralda Neves AU - Ana Tavares AU - Carlos Vasconcelos AU - Elena Trombetta AU - Gaia Montanelli AU - Barbara Vigone AU - Damiana Alvarez-Errico AU - Tianlu Li AU - Ricardo Blanco Alonso AU - Alfonso Corrales Martínez AU - Fernanda Genre AU - Raquel López Mejías AU - Miguel A. Gonzalez-Gay AU - Sara Remuzgo AU - Begoña Ubilla Garcia AU - Ricard Cervera AU - Gerard Espinosa AU - Ignasi Rodríguez-Pintó AU - Ellen De Langhe AU - Jonathan Cremer AU - Rik Lories AU - Doreen Belz AU - Nicolas Hunzelmann AU - Niklas Baerlecken AU - Katja Kniesch AU - Torsten Witte AU - Michaela Lehner AU - Georg Stummvoll AU - Michael Zauner AU - Maria Angeles Aguirre-Zamorano AU - Nuria Barbarroja AU - Maria Carmen Castro-Villegas AU - Eduardo Collantes-Estevez AU - Enrique de Ramon AU - Isabel Díaz Quintero AU - Alejandro Escudero-Contreras AU - María Concepción Fernández Roldán AU - Yolanda Jiménez Gómez AU - Inmaculada Jiménez Moleón AU - Rosario Lopez-Pedrera AU - Rafaela Ortega-Castro AU - Norberto Ortego AU - Enrique Raya AU - Carolina Artusi AU - Maria Gerosa AU - Pier Luigi Meroni AU - Tommaso Schioppo AU - Aurélie De Groof AU - Julie Ducreux AU - Bernard Lauwerys AU - Anne-Lise Maudoux AU - Divi Cornec AU - Valérie Devauchelle-Pensec AU - Sandrine Jousse-Joulin AU - Pierre-Emmanuel Jouve AU - Bénédicte Rouvière AU - Alain Saraux AU - Quentin Simon AU - Montserrat Alvarez AU - Carlo Chizzolini AU - Aleksandra Dufour AU - Donatienne Wynar AU - Attila Balog AU - Márta Bocskai AU - Magdolna Deák AU - Sonja Dulic AU - Gabriella Kádár AU - László Kovács AU - Qingyu Cheng AU - Velia Gerl AU - Falk Hiepe AU - Laleh Khodadadi AU - Silvia Thiel AU - Emanuele de Rinaldis AU - Sambasiva Rao AU - Robert J.Benschop AU - Chris Chamberlain AU - Ernst R. Dow AU - Yiannis Ioannou AU - Laurence Laigle AU - Jacqueline Marovac AU - Jerome Wojcik AU - Yves Renaudineau AU - Maria Orietta Borghi AU - Johan Frostegård AU - Javier Martín AU - Lorenzo Beretta AU - Esteban Ballestar AU - Fiona McDonald AU - Jacques-Olivier Pers AU - Marta E. Alarcón-Riquelme Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/02/23/2020.02.21.20021618.abstract N2 - Background Clinical heterogeneity, a hallmark of systemic autoimmune diseases (SADs) impedes early diagnosis and effective treatment, issues that may be addressed if patients could be grouped into a molecular defined stratification.Methods With the aim of reclassifying SADs independently of the clinical diagnoses, unsupervised clustering of integrated whole blood transcriptome and methylome cross-sectional data of 918 patients with 7 SADs and 263 healthy controls was undertaken. In addition, an inception cohort was prospectively followed for 6 and 14 months to validate the results and analyze if cluster assignment changed or not with time.Results Four clusters were identified. Three clusters were aberrant, representing ‘inflammatory’, ‘lymphoid’, and ‘interferon’ patterns each including all diagnoses and defined by genetic, clinical, serological and cellular features. A fourth cluster showed no specific molecular pattern and accumulated also healthy controls. An independent inception cohort showed that with time, the molecular clusters remain stable, showing that single aberrant molecular signatures characterize each individual patient.Conclusions Patients with SADs can be jointly stratified into three stable disease clusters with specific molecular patterns differentiating different molecular disease mechanisms. These results have important implications for future clinical trials and the study of therapy non-responsiveness marking a paradigm shift in the view of SADs.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02890121NCT02890134Funding StatementThis work has been supported through a grant from the Innovative Medicines Initiative Joint Undertaking No. 115565 and in-kind and in-cash contributions from the EFPIA partners. G.B. is supported by the Instituto de Salud Carlos III (ISCIII, Spanish Health Ministry), through the Sara Borrell subprogram (CD18/00153).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be transferred to ELIXIR and made available upon request and in agreement with the privacy rules of the European Union. ER -